IPO - Actuate pancreatic cancer drug developer files for $50M IPO
2024-05-28 17:48:22 ET
More on Actuate Therapeutics, Inc.
- Actuate Therapeutics Seeks IPO For Promising Pancreatic Cancer Drugs
- Financial information for Actuate Therapeutics, Inc.
This is an AMP page which is for mobile devices.
Link your Twitter Account to Market Wire News
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
2024-05-28 17:48:22 ET
Company Name: | Renaissance IPO |
Stock Symbol: | IPO |
Market: | NYSE |
News, Short Squeeze, Breakout and More Instantly...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.